News
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Yamo Pharmaceuticals, a clinical-stage biopharmaceutical company dedicated to treating the core symptoms of autism spectrum disorder (ASD), today announced ...
Monteloeder, SL, a subsidiary of SUANNUTRA SA, announces exciting results from a new clinical study regarding its natural, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback